Statements (28)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:alternativeName |
gptkb:prucalopride
|
gptkbp:approvedBy |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
gptkbp:ATCCode |
gptkb:A06AX17
|
gptkbp:CASNumber |
gptkb:179474-86-7
|
gptkbp:chemicalFormula |
C18H26N2O4
|
gptkbp:developedBy |
gptkb:Janssen_Pharmaceutica
|
gptkbp:hasInChIKey |
QZVZEKDOQGSQPA-UHFFFAOYSA-N
|
gptkbp:hasSMILES |
CC1=CC(=O)N(C2=CC=CC=C12)CCN3CCC(CC3)C(=O)O
|
https://www.w3.org/2000/01/rdf-schema#label |
SR95531
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
stimulates colonic peristalsis
|
gptkbp:molecularWeight |
350.41 g/mol
|
gptkbp:PubChem_CID |
gptkb:CHEMBL1201197
9941576 DB06272 |
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache |
gptkbp:UNII |
K7V3F8V5CA
|
gptkbp:usedAs |
serotonin 5-HT4 receptor agonist
|
gptkbp:usedFor |
treatment of chronic constipation
|
gptkbp:bfsParent |
gptkb:gabazine
|
gptkbp:bfsLayer |
7
|